Rosetta Genomics Announces Conference Call and Webcast of First Quarter Financial Results

Thursday, May 15, 2008 General News J E 4
REHOVOT, Israel and JERSEY CITY, New Jersey, May 14 Rosetta Genomics (Nasdaq: ROSG), today announced itwill release first quarter financial results on May 21, 2008, before the open. Rosetta Genomics will host a conference call with asimultaneous webcast to discuss these results at 4:30 p.m. ET on May 21.

To access the live conference call, U.S. and Canadian participants maydial +1-866-966-5335; international participants may dial +44-20-3023-4460.To access the 24-hour audio replay, U.S. and Canadian participants may dial+1-866-583-1035; international participants may dial +44-20-8196-1998. Theaccess code for the replay is 181543#. The replay will be available until May28, 2008.

A live audio webcast of the call will also be available on the"Investors" section of the company's website, archived webcast will be available on the Company's website approximatelytwo hours after the event, and will be archived for 30 days thereafter.

About Rosetta Genomics

Rosetta Genomics (Nasdaq: ROSG) is a leader in the field of microRNA.Founded in 2000, the company's integrative research platform combiningbioinformatics and state-of-the-art laboratory processes has led to thediscovery of hundreds of biologically validated novel human microRNAs .Building on its strong IP position and proprietary platform technologies,Rosetta Genomics is working on the application of these technologies in thedevelopment of a full range of microRNA-based diagnostic and therapeutictools, focusing primarily on cancer and various women's health indications.The company expects that the first microRNA diagnostic tests applying itstechnology will be launched by licensed clinical laboratories in the UnitedStates in 2008.Contact: Media Rachel Spielman T: +1-212-583-271 E: Investors Ron Kamienchick T: +1-646-509-1893 E:

SOURCE Rosetta Genomics Ltd


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
SI International Awarded $11 Million Health Servic...
Novavax CEO to Present at ACUMENBioFin's 5th Annua...